247 related articles for article (PubMed ID: 25524906)
1. A London experience 1995-2012: demographic, dietary and biochemical characteristics of a large adult cohort of patients with renal stone disease.
Ferraro PM; Robertson WG; Johri N; Nair A; Gambaro G; Shavit L; Moochhala SH; Unwin RJ
QJM; 2015 Jul; 108(7):561-8. PubMed ID: 25524906
[TBL] [Abstract][Full Text] [Related]
2. Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
Huynh LM; Dianatnejad S; Tofani S; Carrillo Ceja R; Liang K; Tapiero S; Jiang P; Youssef RF
Scand J Urol; 2020 Dec; 54(6):456-462. PubMed ID: 33185135
[TBL] [Abstract][Full Text] [Related]
3. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
Curhan GC; Willett WC; Speizer FE; Stampfer MJ
Kidney Int; 2001 Jun; 59(6):2290-8. PubMed ID: 11380833
[TBL] [Abstract][Full Text] [Related]
4. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
[TBL] [Abstract][Full Text] [Related]
5. Metabolic evaluation in patients with infected nephrolithiasis: Is it necessary?
Cicerello E; Mangano M; Cova GD; Merlo F; Maccatrozzo L
Arch Ital Urol Androl; 2016 Oct; 88(3):208-211. PubMed ID: 27711095
[TBL] [Abstract][Full Text] [Related]
6. Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features.
McPhail EF; Gettman MT; Patterson DE; Rangel LJ; Krambeck AE
Urology; 2012 Feb; 79(2):277-81. PubMed ID: 22014971
[TBL] [Abstract][Full Text] [Related]
7. A multiregional Italian cohort of 24-hour urine metabolic evaluation in renal stone formers.
Esperto F; Marangella M; Trinchieri A; Petrarulo M; Miano R
Minerva Urol Nefrol; 2018 Feb; 70(1):87-94. PubMed ID: 28882031
[TBL] [Abstract][Full Text] [Related]
8. Metabolic disorders in Turkish children with urolithiasis.
Celiksoy MH; Yilmaz A; Aydogan G; Kiyak A; Topal E; Sander S
Urology; 2015 Apr; 85(4):909-13. PubMed ID: 25817115
[TBL] [Abstract][Full Text] [Related]
9. Effects of dietary interventions on 24-hour urine parameters in patients with idiopathic recurrent calcium oxalate stones.
Kıraç M; Küpeli B; Irkilata L; Gülbahar O; Aksakal N; Karaoğlan U; Bozkırlı I
Kaohsiung J Med Sci; 2013 Feb; 29(2):88-92. PubMed ID: 23347810
[TBL] [Abstract][Full Text] [Related]
10. Daily Green Tea Infusions in Hypercalciuric Renal Stone Patients: No Evidence for Increased Stone Risk Factors or Oxalate-Dependent Stones.
Rode J; Bazin D; Dessombz A; Benzerara Y; Letavernier E; Tabibzadeh N; Hoznek A; Tligui M; Traxer O; Daudon M; Haymann JP
Nutrients; 2019 Jan; 11(2):. PubMed ID: 30678344
[TBL] [Abstract][Full Text] [Related]
11. Biochemical diagnosis in 3040 kidney stone formers in Argentina.
Spivacow FR; del Valle EE; Negri AL; Fradinger E; Abib A; Rey P
Urolithiasis; 2015 Aug; 43(4):323-30. PubMed ID: 25958053
[TBL] [Abstract][Full Text] [Related]
12. The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.
Wu W; Yang D; Tiselius HG; Ou L; Liang Y; Zhu H; Li S; Zeng G
Urology; 2014 Apr; 83(4):732-7. PubMed ID: 24485999
[TBL] [Abstract][Full Text] [Related]
13. Vascular calcification and bone mineral density in recurrent kidney stone formers.
Shavit L; Girfoglio D; Vijay V; Goldsmith D; Ferraro PM; Moochhala SH; Unwin R
Clin J Am Soc Nephrol; 2015 Feb; 10(2):278-85. PubMed ID: 25635036
[TBL] [Abstract][Full Text] [Related]
14. Metabolic abnormalities associated with calyceal diverticular stones.
Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
[TBL] [Abstract][Full Text] [Related]
15. Ethnic background has minimal impact on the etiology of nephrolithiasis.
Maloney ME; Springhart WP; Ekeruo WO; Young MD; Enemchukwu CU; Preminger GM
J Urol; 2005 Jun; 173(6):2001-4. PubMed ID: 15879804
[TBL] [Abstract][Full Text] [Related]
16. High Prevalence of Hypocitraturia in Stone Formers from the Maya Region of Yucatan, Mexico.
Basulto-Martínez M; Peña-Espinoza B; Valdez-Ortiz R; Escalante-Sosa R; Flores-Tapia JP; Menjivar M
Arch Med Res; 2022 Jan; 53(1):69-78. PubMed ID: 34243991
[TBL] [Abstract][Full Text] [Related]
17. The growing prevalence of kidney stones and opportunities for prevention.
Richman K; O'Bell J; Pareek G
R I Med J (2013); 2014 Dec; 97(12):31-4. PubMed ID: 25463625
[TBL] [Abstract][Full Text] [Related]
18. Obesity and urolithiasis: evidence of regional influences.
Trinchieri A; Croppi E; Montanari E
Urolithiasis; 2017 Jun; 45(3):271-278. PubMed ID: 27488444
[TBL] [Abstract][Full Text] [Related]
19. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
Hess B
Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers.
Eisner BH; Sheth S; Dretler SP; Herrick B; Pais VM
Urology; 2012 Oct; 80(4):776-9. PubMed ID: 22921696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
